-
Sector Analysis
Atrial Fibrillation Major Markets Drug Forecast and Market Analysis
The table below presents the key metrics for atrial fibrillation (AF) in the eight major pharmaceutical markets (8MM) covered in this report—the US, 5EU (France, Germany, Italy, Spain, and the UK), Japan, and Canada—during the forecast period from 2022–32. In 2022, GlobalData estimated that the global AF market reached $14.5 billion across the 8MM. The US makes up the majority of total global sales, contributing $10.7 billion (74%) due to the large prevalent AF population in the US, early adoption...
-
Product Insights
Basal Cell Carcinoma (Basal Cell Epithelioma): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) - Global Clinical Trials Review, 2025" provides an overview of Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Basal Cell Carcinoma (Basal Cell Epithelioma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) - Global Clinical Trials Review, 2025" provides an overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by...
-
Product Insights
Herpes Zoster (Shingles): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Herpes Zoster (Shingles) - Global Clinical Trials Review, 2025" provides an overview of Herpes Zoster (Shingles) Clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Epilepsy: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Epilepsy - Global Clinical Trials Review, 2025" provides an overview of Epilepsy Clinical trials scenario. This report provides top line data relating to the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Focal Segmental Glomerulosclerosis (FSGS: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) - Global Clinical Trials Review, 2025" provides an overview of Focal Segmental Glomerulosclerosis (FSGS) Clinical trials scenario. This report provides top line data relating to the clinical trials on Focal Segmental Glomerulosclerosis (FSGS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Pustular Psoriasis: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Pustular Psoriasis - Global Clinical Trials Review, 2025" provides an overview of Pustular Psoriasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pustular Psoriasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Overweight: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Overweight - Global Clinical Trials Review, 2025" provides an overview of Overweight Clinical trials scenario. This report provides top line data relating to the clinical trials on Overweight. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Alopecia Areata Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033
This report deliverables include a PowerPoint report and an Excel-based forecast model and covers the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The base year of the sales forecast model is 2023, and the forecast period is 2023-2033. This report also includes a number of recent enhancement to the forecast models, specifically the US LoA analysis tab and the interactive patient flow tab. The patient flow tab helps to summarize the number of patients treated...
-
Sector Analysis
Idiopathic Pulmonary Fibrosis: Epidemiology Forecast to 2034
Idiopathic pulmonary fibrosis (IPF), a type of interstitial lung disease (ILD), is a serious chronic condition that affects the tissue surrounding the air sacs, or alveoli, in the lungs (National Heart Lung and Blood Institute, 2023). Environmental factors such as smoking, chronic aspiration, or respiratory infections, combined with advancing age, are the likely driving factors for the pathogenesis of IPF by causing respiratory alveolar epithelial injury (Sankari, Chapman and Ullah, 2024). These factors can cause permanent scarring in the lungs,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.